We are live on ! Find out more
DNTH icon

Dianthus Therapeutics

74 hedge funds and large institutions have $769M invested in Dianthus Therapeutics in 2024 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 16

17% more funds holding in top 10

Funds holding in top 10: 67 (+1)

12.35% more ownership

Funds ownership: 88.85%101.2% (+12%)

2% less capital invested

Capital invested by funds: $782M → $769M (-$13.5M)

7% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 30

3% less funds holding

Funds holding: 7674 (-2)

Holders
74
Holders Change
-2
Holders Change %
-2.63%
% of All Funds
1.07%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.1%
New
28
Increased
19
Reduced
16
Closed
30
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
TRCT
101
Tower Research Capital (TRC)
New York
-$117K -3,897 Closed
Macquarie Group
102
Macquarie Group
Australia
-$55 -1,824 Closed
EC
103
EntryPoint Capital
New York
-$10.9K -363 Closed
FIM
104
Fernwood Investment Management
Massachusetts
-$3.06K -102 Closed